The CMG2 ELISA for evaluating inhibitors of the binding of anthrax toxin protective antigen to its receptor
- 1 January 2009
- journal article
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 59 (1) , 50-55
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- EMILINs interact with anthrax protective antigen and inhibit toxin action in vitroMatrix Biology, 2008
- Catalytically inactive anthrax toxin(s) are potential prophylactic agentsVaccine, 2007
- Where and how do anthrax toxins exit endosomes to intoxicate host cells?Trends in Microbiology, 2007
- Polyvalent inhibitors of anthrax toxin that target host receptorsProceedings of the National Academy of Sciences, 2006
- Detection of Anthrax Toxin in the Serum of Animals Infected with Bacillus anthracis by Using Engineered ImmunoassaysClinical and Vaccine Immunology, 2006
- Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre platesJournal of Applied Toxicology, 2005
- Binding Stoichiometry and Kinetics of the Interaction of a Human Anthrax Toxin Receptor, CMG2, with Protective AntigenJournal of Biological Chemistry, 2004
- Human capillary morphogenesis protein 2 functions as an anthrax toxin receptorProceedings of the National Academy of Sciences, 2003
- Identification of the cellular receptor for anthrax toxinNature, 2001
- Characterization of the asialofetuin microtitre plate-binding assay for evaluating inhibitors of ricin lectin activityJournal of Applied Toxicology, 1999